Xbiotech Inc (NQ: XBIT )

15.83 USD -0.10 (-0.63%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2021 Add to My Watchlist

Price and Volume

Volume	79,759
Open	15.99
Bid (Size)	15.75 (3)
Ask (Size)	15.83 (2)
Prev. Close	15.93
Today's Range	15.35 - 16.00
52wk Range	13.69 - 21.48
Shares Outstanding	29,983,801
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

French National Cancer Institute and XBiotech Join forces to Conduct Innovative Phase II/III Adaptive Multicenter Clinical Study for XBiotech’s New Cancer Drug for Colorectal Cancer

May 03, 2021

XBiotech to Supply INSERM its New Drug to Use in Combination Therapy for Treating Advanced Colorectal Cancer

FDA Gives Go-Ahead for XBiotech’s Candidate Therapy for Phase I/II Double-blind Placebo Controlled Study in Pancreatic Cancer

April 19, 2021

XBiotech’s New Drug to Enter Clinical Studies in Combination Therapy for Pancreatic Cancer

Performance

YTD	-2.10%	-2.10%
1 Month	-7.70%	-7.70%
3 Month	-18.99%	-18.99%
6 Month	-6.50%	-6.50%
1 Year	+7.61%	+7.61%

More News

XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain

January 21, 2021

XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy

January 19, 2021

XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail

November 19, 2020

XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections

September 21, 2020

XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization

August 24, 2020

XBiotech Discovers COVID-19 Candidate Therapy

August 17, 2020

XBiotech To Test New Drug Candidate Combined With Approved Treatment In Pancreatic Cancer

April 19, 2021

12 Health Care Stocks Moving In Tuesday's Intraday Session

March 30, 2021

COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial

March 03, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.